药物递送制剂和技术
纳米制剂开发的分步说明
让药物递送制剂和颗粒合成变得简单
药物递送制剂对于许多活性药物成分(API)的递送、功效和稳定性都是必需的,并随着近期mRNA疫苗和其他核酸等疗法的进展而变得尤为重要。
我们的NanoFabTx™制剂试剂盒专为从纳米级到微米级载药颗粒的简便且可重现合成而设计。针对纳米制剂的开发提供了带有分步教程的详细实验方案,无需进行冗长的试错优化。NanoFabTx™制剂试剂盒和脂质混合物既可与传统的纳米沉淀或挤出方法一共使用,也可与NanoFabTx™微流控设备套件结合使用,用于快速合成成分明确的药物递送颗粒。
相关资源
- Article: NanoFabTx™ – A ready-to-use Microfluidic Platform for mRNA Vaccine Formulation
NanoFabTx offers a microfluidic platform for mRNA vaccine formulation, aiding in preclinical assessments.
- Article: NanoFabTx™ Nanoparticle and mRNA Liposome Formulation Using the NanoAssemblr®
NanoFabTX kits enable precise drug delivery with lipid nanoparticles and liposomes for mRNA and nucleic acids.
- PDF: Material Matters 14.3 – Advanced Tools for Drug Delivery Research
Nanoparticle drug delivery systems are emerging as a useful tool for achieving controlled and targeted delivery of drug molecules and thereby enhancing therapeutic effect. The cover art for this issue depicts microfluidic-assisted nanoformulation, one method for fabricating liposomes and polymeric nanoparticles for the delivery of smallmolecule and biological drugs.
- Brochure: The Future of Drug Delivery: Lyophilized Liposome Flyer
Liposomes are one of the most common drug delivery carriers for small molecules and nucleic acid therapeutics.
如要继续阅读,请登录或创建帐户。
暂无帐户?